Healthcare professionals who adapted inpatient diabetes care during the pandemic will be celebrated with the revamped Rowan Hillson Inpatient Safety Award.
The focus of this year’s award is: ‘The best interventions: Redesigning, rebuilding and maintaining safe inpatient diabetes care during COVID,’ with judges looking for applications which:
- Show hard evidence of benefit
- Are translatable to other Trusts
- Are costed
- Are relatively simple and sustainable
- Have been commissioned or supported by an Acute Trust.
The JBDS – IP competition is open to all UK health care professionals and is led by Dr Umesh Dashora 
and Diabetes Nurse Consultant Erwin Castro. It did not take place last year due to the pressures on hospital teams during the pandemic.
Dr Dashora, Consultant Endocrinologist and Diabetologist at East Sussex Healthcare NHS Trust, said: “Over the years Rowan Hillson Awards have discovered many excellent innovations and practices throughout the country. I am sure this award will identify excellent novel approaches for maintaining safe in-patient diabetes care during COVID times.”
Entries will be judged against predetermined criteria by an independent panel chaired by Rowan Hillson, with the winner presented with the award at the ABCD Spring meeting 2022. In addition, details of the winning entry will be published on the ABCD, Diabetes UK and DISN UK Group websites to share excellent practice.
The closing date for entries is February 28, 2022 – click here to view the entry form.
Please note this competition is only for projects undertaken during the COVID pandemic.